Will Thomas/LinkedIn
Jul 29, 2026, 10:30
Will Thomas: The New Evidence on Delayed Anticoagulation and PE Mortality
Will Thomas, Consultant haematologist at Cambridge University Hospitals NHS Foundation Trust, shared on LinkedIn about a recent article by Kelsey E. Bria et al, published in JTH, adding:
”Causation can be very challenging for experts in cases where there has been delayed anticoagulation and mortality from pulmonary embolism.
This publication provides valuable data in this area.”
Title: Time-to-start of anticoagulant therapy and mortality in pulmonary embolism
Authors: Kelsey E. Bria, Brian F. Gage, Alejandra Gutierrez, Caleb J. Chiang, Jia Qi Xiong, Serena Flórez-Marqués, Cameron Upchurch, Melissa Beasley, Kristen M. Sanfilippo
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke